Emergent drugs to be directly supplied by makers to hospitals.

An emergent or special drug having a short half life, say, 48 hours or so forth, could not be supplied through the wholesalers from its makers pursuant the current unified distribution provisions in view of its short shelf life and the time for its distribution process. In such case, the MOHW may apply exceptional rules.

"Holoderm", a cellular therapeutic agent manufactured by Taego Science,...